Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance) - Lenz, H J; Ou, F S; Venook, A P (2017)
(suppl; abstr 3511)